"The January SPL UK trial report might mean UK soon agrees to ANTIVIRAL SPRAY on box instead of BARRIER SPRAY "
So would it also need to include "only over 45 YO achieved a statistically significant improvement" in a human trial. Can you tell me another similar product that is age limited to over 45 adults?
If not why not after all the complete trial failed as it didn't achieve a statistically significant result across all cohorts
Only after subset cohort analysis was SPL able to produce a subgroup result that showed in over 45 yo subgroup and over in the trial succeeded and SPL chose not to give enough data for SPL shareholders to understand why other cohorts subgroups
"The January SPL UK trial report might mean UK soon agrees to...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $40.79M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $24.18K | 241.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 428888 | 7 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.3¢ | 10.5¢ | 10.0¢ | 168392 | ||
| Last updated 15.48pm 13/06/2024 ? | |||||
| SPL (ASX) Chart |